Anbio Biotechnology (NNNN) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $5348.5 billion.

  • Anbio Biotechnology's Cash & Equivalents changed N/A to $5348.5 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5348.5 billion, marking a year-over-year change of. This contributed to the annual value of $11.8 million for FY2024, which is 2139.65% up from last year.
  • As of Q2 2025, Anbio Biotechnology's Cash & Equivalents stood at $5348.5 billion.
  • Anbio Biotechnology's 5-year Cash & Equivalents high stood at $5348.5 billion for Q2 2025, and its period low was $9.7 million during Q4 2023.
  • Moreover, its 3-year median value for Cash & Equivalents was $11.8 million (2024), whereas its average is $1782.8 billion.
  • Over the last 5 years, Anbio Biotechnology's Cash & Equivalents had its largest YoY gain of 2139.65% in 2024, and its largest YoY loss of 2139.65% in 2024.
  • Over the past 3 years, Anbio Biotechnology's Cash & Equivalents (Quarter) stood at $9.7 million in 2023, then rose by 21.4% to $11.8 million in 2024, then surged by 45476935.31% to $5348.5 billion in 2025.
  • Its last three reported values are $5348.5 billion in Q2 2025, $11.8 million for Q4 2024, and $9.7 million during Q4 2023.